Leqi Shen. (2023). HR-Positive Breast Cancer and New Potentially Synergistic Approaches with CDK Inhibition of the Retinoblastoma Protein and CAR T-Cell Immunotherapy. ournal of nnovations in edical esearch, 2(11), 24–27. etrieved from https://www.paradigmpress.org/jimr/article/view/860